Rocacetrapib

CAS : 1402796-27-3

Ref. 3D-CGC79627

Informations sur le produit

• Nom: Rocacetrapib
• Marque: Biosynth
• Description: Rocacetrapib is an investigational drug that belongs to the class of cholesteryl ester transfer protein (CETP) inhibitors. It has been shown to have antiviral activity against SARS-CoV and may be useful in the treatment of other viruses, such as HIV and influenza. Rocacetrapib has also been shown to inhibit cell growth and induce apoptosis in human lung cancer cells, which are resistant to cisplatin. This compound also binds to proteinase 3, suggesting a potential use in the treatment of Alzheimer's disease.

Propriétés chimiques

• Masse moléculaire: 601.6 g/mol
• Formule: C₃₁H₃₄F₇NO₃
• Degré de pureté: Min. 95%